These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 9422069

  • 1. [Multi-drug antiemetic treatment and effect of treatment duration of concurrent steroids--for complete control of chemotherapy-induced nausea/vomiting in gynecological cancer].
    Fujii T, Nakata N, Shiroyama Y, Sawasaki T, Tanimoto H, Shigemasa K, Kioka H, Naito H.
    Gan To Kagaku Ryoho; 1997 Dec; 24(15):2245-52. PubMed ID: 9422069
    [Abstract] [Full Text] [Related]

  • 2. [Effect of concurrent use of ondansetron hydrochloride and dexamethasone against nausea and vomiting in lung cancer patients receiving cisplatin].
    Tanimura S, Banba J, Tomoyasu H, Masaki M.
    Gan To Kagaku Ryoho; 1998 Dec; 25(14):2275-81. PubMed ID: 9881085
    [Abstract] [Full Text] [Related]

  • 3. Antiemetic effect of ondansetron and dexamethasone in gynecologic malignant patients receiving chemotherapy.
    Pradermdee P, Manusirivithaya S, Tangjitgamol S, Thavaramara T, Sukwattana P.
    J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S29-36. PubMed ID: 17725140
    [Abstract] [Full Text] [Related]

  • 4. [Examination on efficacy and safety of concurrent use of ondansetron hydrochloride and steroid in gynecological cancer patients on cisplatin].
    Eguchi F, Taguchi T, Furue H, Ikeda M, Tsukakoshi S, Gan KenKyu-kai (the Cancer Study Group).
    Gan To Kagaku Ryoho; 2001 Oct; 28(10):1423-9. PubMed ID: 11681251
    [Abstract] [Full Text] [Related]

  • 5. [Clinical efficacy of GG032X tablets, a new dosage form of ondansetron (fast dispersing tablet), on cisplatin-induced nausea and emesis].
    Ariyoshi Y, Nukariya N, Akasaka Y, Suminaga M, Ota J, Ikeda M, Taguchi T.
    Gan To Kagaku Ryoho; 1997 Jun; 24(8):995-1011. PubMed ID: 9212810
    [Abstract] [Full Text] [Related]

  • 6. [Efficacy of combination of ondansetron injection and tablet in CAF-induced emesis in breast cancer patients].
    Shinohara H, Yonekawa H, Machimura T, Furukawa T, Nishihori H, Kurihara N, Urakami H, Nemoto Y.
    Gan To Kagaku Ryoho; 1998 Feb; 25(3):397-402. PubMed ID: 9492834
    [Abstract] [Full Text] [Related]

  • 7. [Effect of ondansetron hydrochloride injection and tablet against nausea and vomiting in lung cancer patients receiving carboplatin].
    Miyamoto Y, Yagi K, Teramachi M, Oomasa M, Tomiyama K.
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):125-30. PubMed ID: 9987508
    [Abstract] [Full Text] [Related]

  • 8. A study evaluating the efficacy and tolerability of tropisetron in combination with dexamethasone in the prevention of delayed platinum-induced nausea and emesis.
    Sorbe BG, Berglind AM, Andersson H, Boman K, Högberg T, Hallgren M, Schmidt M.
    Cancer; 1998 Sep 01; 83(5):1022-32. PubMed ID: 9731907
    [Abstract] [Full Text] [Related]

  • 9. The antiemetic efficacy of oral ondansetron plus intravenous dexamethasone in patients with gynecologic malignancies receiving carboplatin-based chemotherapy.
    Markman M, Kennedy A, Webster K, Peterson G, Kulp B, Belinson J.
    Gynecol Oncol; 2000 Jul 01; 78(1):43-6. PubMed ID: 10873408
    [Abstract] [Full Text] [Related]

  • 10. Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting. Results from a randomized, double-blind, placebo-controlled trial in Latin America.
    Poli-Bigelli S, Rodrigues-Pereira J, Carides AD, Julie Ma G, Eldridge K, Hipple A, Evans JK, Horgan KJ, Lawson F, Aprepitant Protocol 054 Study Group.
    Cancer; 2003 Jun 15; 97(12):3090-8. PubMed ID: 12784346
    [Abstract] [Full Text] [Related]

  • 11. [Examination on efficacy and safety of concurrent use of ondansetron hydrochloride and steroid in lung cancer patients on cisplatin].
    Horichi N, Taguchi T, Furue H, Ikeda M, Tsukakoshi S.
    Gan To Kagaku Ryoho; 2001 Jul 15; 28(7):953-60. PubMed ID: 11478144
    [Abstract] [Full Text] [Related]

  • 12. [A randomized cross-over comparative study of granisetron alone and combination of granisetron, methylprednisolone and droperidol as antiemetic prophilaxis in CDDP-based chemotherapy for gynecologic cancer].
    Wataba K, Sagae S, Fukunaka N, Sugimura M, Akutagawa N, Hayashi T, Yamana K, Nakamura T, Terasawa K, Mizumoto H, Kitajima Y, Kudo R.
    Gan To Kagaku Ryoho; 1997 Apr 15; 24(6):691-7. PubMed ID: 9126306
    [Abstract] [Full Text] [Related]

  • 13. Phase II trial of ramosetron plus dexamethasone in the prevention of cisplatin-induced nausea and vomiting.
    Voravud N, Sriuranpong V.
    J Med Assoc Thai; 2005 Dec 15; 88(12):1790-6. PubMed ID: 16518975
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the efficacy and safety of oral granisetron plus dexamethasone with intravenous ondansetron plus dexamethasone to control nausea and vomiting induced by moderate/severe emetogenic chemotherapy.
    Chiou TJ, Tzeng WF, Wang WS, Yen CC, Fan FS, Liu JH, Chen PM.
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Oct 15; 63(10):729-36. PubMed ID: 11076429
    [Abstract] [Full Text] [Related]

  • 15. Management of platinum-based chemotherapy-induced acute nausea and vomiting: is there a superior serotonin receptor antagonist?
    Hamadani M, Chaudhary L, Awan FT, Khan JK, Kojouri K, Ozer H, Tfayli A.
    J Oncol Pharm Pract; 2007 Jun 15; 13(2):69-75. PubMed ID: 17873106
    [Abstract] [Full Text] [Related]

  • 16. [Clinical studies of oral antiemetic drugs on delayed emesis induced by cancer chemotherapy].
    Sawaguchi K, Yabushita H, Tsukada H, Yamada H, Noguchi M, Nakanishi M.
    Gan To Kagaku Ryoho; 1999 Jan 15; 26(1):117-23. PubMed ID: 9987507
    [Abstract] [Full Text] [Related]

  • 17. Antiemetic efficacy of high-dose intravenous metoclopramide and dexamethasone in patients receiving cisplatin-based chemotherapy: a randomized controlled trial.
    Shinkai T, Saijo N, Eguchi K, Sasaki Y, Tamura T, Tominaga K, Sakurai M, Sano T, Taito H, Takahashi H.
    Jpn J Clin Oncol; 1986 Sep 15; 16(3):279-87. PubMed ID: 3534348
    [Abstract] [Full Text] [Related]

  • 18. Comparison of antiemetic efficacy between single and repeat treatment with dexamethasone in patients receiving carboplatin-based combination chemotherapy.
    Kawazoe H, Motoki Y, Takechi Y, Shishino Y, Ido K, Suemaru K, Araki H.
    Methods Find Exp Clin Pharmacol; 2010 Sep 15; 32(7):499-505. PubMed ID: 21069101
    [Abstract] [Full Text] [Related]

  • 19. [Clinical usefulness of ondansetron hydrochloride for nausea and vomiting during repeated courses of chemotherapy for malignant lymphoma--impact of prognosis announcement on anti-emetic effect and evaluation of patient perception of chemotherapy-associated adverse events].
    Kodama F, Mohri H, Motomura S, Fukawa H, Tanabe J, Koharasawa H, Kanamori H, Hashimoto Y, Harano H, Sakai R, Tomita N, Fujimaki K, Takemura S, Hattori M.
    Gan To Kagaku Ryoho; 2002 Feb 15; 29(2):273-9. PubMed ID: 11865634
    [Abstract] [Full Text] [Related]

  • 20. [Gastrointestinal toxicity induced by anticancer drugs--including new antiemetic drugs].
    Sampi K, Taguchi T.
    Gan To Kagaku Ryoho; 1990 Apr 15; 17(4 Pt 2):922-8. PubMed ID: 2140498
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.